Published in Biochem Biophys Rep on January 23, 2016
MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 10.11
The story of Rett syndrome: from clinic to neurobiology. Neuron (2007) 8.08
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol (2010) 4.72
MEF2: a central regulator of diverse developmental programs. Development (2007) 4.70
Something about SUMO inhibits transcription. Curr Opin Genet Dev (2005) 4.05
Regulation of DNA damage responses by ubiquitin and SUMO. Mol Cell (2013) 3.43
SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem (2008) 3.22
Mechanisms, regulation and consequences of protein SUMOylation. Biochem J (2010) 3.22
The role of MeCP2 in the brain. Annu Rev Cell Dev Biol (2011) 2.84
Ubiquitin signalling in DNA replication and repair. Nat Rev Mol Cell Biol (2010) 2.41
The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting. Nature (2009) 2.40
Activity-dependent neuronal signalling and autism spectrum disorder. Nature (2013) 2.23
Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci (2007) 1.97
Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell (2013) 1.80
Uncovering global SUMOylation signaling networks in a site-specific manner. Nat Struct Mol Biol (2014) 1.74
Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One (2008) 1.45
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. Cell Mol Life Sci (2011) 1.25
Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation. Am J Med Genet A (2005) 1.21
Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals. Eur J Neurosci (2009) 1.18
Homeostatic synaptic scaling is regulated by protein SUMOylation. J Biol Chem (2012) 1.06
Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction. Physiol Rev (2014) 1.02
Refining the phenotype associated with MEF2C point mutations. Neurogenetics (2012) 0.93
The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome. Mol Syndromol (2012) 0.92
Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies. Nat Protoc (2014) 0.91
SUMOylation is required for glycine-induced increases in AMPA receptor surface expression (ChemLTP) in hippocampal neurons. PLoS One (2013) 0.89
SUMOylation of MeCP2 is essential for transcriptional repression and hippocampal synapse development. J Neurochem (2013) 0.84
A national survey of Rett syndrome: behavioural characteristics. J Neurodev Disord (2015) 0.83